Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania

British Journal of Haematology

Volumn 165, Issue 5, 2014, Pages 699-706

  Cox, Sharon E ^a,b   Makani, Julie ^b,c   Soka, Deogratias ^b   L'Esperence, Veline S ^d   Kija, Edward ^b   Dominguez Salas, Paula ^a   Newton, Charles R J ^b,e,f   Birch, Anthony A ^g   Prentice, Andrew M ^a   Kirkham, Fenella J ^h  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Africa; Cerebral blood flow velocity; Children; Sickle cell disease

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HAPTOGLOBIN;

ADULT; ALLELE; ALPHA THALASSEMIA; ARTICLE; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HOMOZYGOSITY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SICKLE CELL ANEMIA; TANZANIA; WILD TYPE; ADOLESCENT; BLOOD FLOW VELOCITY; BRAIN CIRCULATION; CHILD; COMPLICATION; ECHOGRAPHY; EPISTASIS; GENETICS; HOMOZYGOTE; INFANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; CHILD; CHILD, PRESCHOOL; EPISTASIS, GENETIC; FEMALE; GENE DELETION; GENOTYPE; GLUCOSEPHOSPHATE DEHYDROGENASE; HAPTOGLOBINS; HOMOZYGOTE; HUMANS; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; YOUNG ADULT;

EID: 84900469368     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12791     Document Type: Article

References (60)

1. Adams, R.J., Nichols, F.T. III, Aaslid, R., McKie, V.C., McKie, K., Carl, E., Stephens, S., Thompson, W.O., Milner, P. & Figueroa, R. (1990) Cerebral vessel stenosis in sickle cell disease: criteria for detection by transcranial Doppler. The American Journal of Pediatric Hematology/Oncology, 12, 277-282.
2. Adams, R.J., Nichols, F.T., Figueroa, R., McKie, V. & Lott, T. (1992) Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke, 23, 1073-1077.
3. Adams, R.J., Kutlar, A., McKie, V., Carl, E., Nichols, F.T., Liu, J.C., McKie, K. & Clary, A. (1994) Alpha thalassemia and stroke risk in sickle cell anemia. American Journal of Hematology, 45, 279-282.
4. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 5-11.
5. Adams, R.J., Brambilla, D.J., Granger, S., Gallagher, D., Vichinsky, E., Abboud, M.R., Pegelow, C.H., Woods, G., Rohde, E.M., Nichols, F.T., Jones, A., Luden, J.P., Bowman, L., Hagner, S., Morales, K.H. & Roach, E.S. (2004) Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood, 103, 3689-3694.
6. Asleh, R., Marsh, S., Shilkrut, M., Binah, O., Guetta, J., Lejbkowicz, F., Enav, B., Shehadeh, N., Kanter, Y., Lache, O., Cohen, O., Levy, N.S. & Levy, A.P. (2003) Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circulation Research, 92, 1193-1200.
7. Azarov, I., He, X., Jeffers, A., Basu, S., Ucer, B., Hantgan, R.R., Levy, A. & Kim-Shapiro, D.B. (2008) Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide, 18, 296-302.
8. Ballas, S.K. (2001) Effect of alpha-globin genotype on the pathophysiology of sickle cell disease. Pediatric Pathology & Molecular Medicine, 20, 107-121.
9. Bartolucci, P., Brugnara, C., Teixeira-Pinto, A., Pissard, S., Moradkhani, K., Jouault, H. & Galacteros, F. (2012) Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis. Blood, 120, 3136-3141.
10. Belcher, J.D., Mahaseth, H., Welch, T.E., Otterbein, L.E., Hebbel, R.P. & Vercellotti, G.M. (2006) Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. Journal of Clinical Investigation, 116, 808-816.
11. Belisario, A.R., Rodrigues, C.V., Martins, M.L., Silva, C.M. & Viana, M.B. (2010) Coinheritance of alpha-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia. Hemoglobin, 34, 516-529.
12. Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M. & Delacourt, C. (2008) G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood, 112, 4314-4317.
13. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coic, L., Leveille, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galacteros, F., Torres, M., Kuentz, M., Ferry, C., Socie, G., Reinert, P. & Delacourt, C. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 1130-1140; quiz 1436.
14. Beutler, E. (2001) Discrepancies between genotype and phenotype in hematology: an important frontier. Blood, 98, 2597-2602.
15. Borsody, M., Burke, A., Coplin, W., Miller-Lotan, R. & Levy, A. (2006) Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology, 66, 634-640.
16. Buchanan, I.D., James-Herry, A. & Osunkwo, I. (2012) The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease. Journal of Pediatric Hematology/oncology, 35, 543-546.
17. Chaichana, K.L., Levy, A.P., Miller-Lotan, R., Shakur, S. & Tamargo, R.J. (2007) Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke, 38, 3266-3271.
18. Chaichana, K.L., Pradilla, G., Huang, J. & Tamargo, R.J. (2010) Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurgery, 73, 22-41.
19. Cid, M.C., Grant, D.S., Hoffman, G.S., Auerbach, R., Fauci, A.S. & Kleinman, H.K. (1993) Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. Journal of Clinical Investigation, 91, 977-985.
20. Cox, S.E., Doherty, C., Atkinson, S.H., Nweneka, C.V., Fulford, A.J., Ghattas, H., Rockett, K.A., Kwiatkowski, D.P. & Prentice, A.M. (2007) Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection. PLoS One, 2, e362.
21. Cox, S.E., Makani, J., Newton, C.R., Prentice, A.M. & Kirkham, F.J. (2013) Hematological and genetic predictors of daytime hemoglobin saturation in tanzanian children with and without sickle cell anemia. ISRN Hematology, 2013, 472909.
22. Eaton, W.A. & Hofrichter, J. (1987) Hemoglobin S gelation and sickle cell disease. Blood, 70, 1245-1266.
23. Embury, S.H., Dozy, A.M., Miller, J., Davis, J.R. Jr, Kleman, K.M., Preisler, H., Vichinsky, E., Lande, W.N., Lubin, B.H., Kan, Y.W. & Mentzer, W.C. (1982) Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. New England Journal of Medicine, 306, 270-274.
24. Embury, S.H., Clark, M.R., Monroy, G. & Mohandas, N. (1984) Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes. Journal of Clinical Investigation, 73, 116-123.
25. Flanagan, J.M., Frohlich, D.M., Howard, T.A., Schultz, W.H., Driscoll, C., Nagasubramanian, R., Mortier, N.A., Kimble, A.C., Aygun, B., Adams, R.J., Helms, R.W. & Ware, R.E. (2011) Genetic predictors for stroke in children with sickle cell anemia. Blood, 117, 6681-6684.
26. Froehler, M.T., Kooshkabadi, A., Miller-Lotan, R., Blum, S., Sher, S., Levy, A. & Tamargo, R.J. (2010) Vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice can be prevented with a glutathione peroxidase mimetic. Journal of Clinical Neuroscience, 17, 1169-1172.
27. Hsu, L.L., Miller, S.T., Wright, E., Kutlar, A., McKie, V., Wang, W., Pegelow, C.H., Driscoll, C., Hurlet, A., Woods, G., Elsas, L., Embury, S. & Adams, R.J. (2003) Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. Journal of Pediatric Hematology/oncology, 25, 622-628.
28. Jison, M.L., Munson, P.J., Barb, J.J., Suffredini, A.F., Talwar, S., Logun, C., Raghavachari, N., Beigel, J.H., Shelhamer, J.H., Danner, R.L. & Gladwin, M.T. (2004) Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood, 104, 270-280.
29. Johnson, M.K., Clark, T.D., Njama-Meya, D., Rosenthal, P.J. & Parikh, S. (2009) Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PLoS One, 4, e7246.
30. Kirkham, F.J., Neville, B.G. & Levin, S.D. (1986) Bedside diagnosis of stenosis of middle cerebral artery. Lancet, 1, 797-798.
31. Koch, W., Latz, W., Eichinger, M., Roguin, A., Levy, A.P., Schomig, A. & Kastrati, A. (2002) Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clinical Chemistry, 48, 1377-1382.
32. Kral, M.C., Brown, R.T., Nietert, P.J., Abboud, M.R., Jackson, S.M. & Hynd, G.W. (2003) Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics, 112, 324-331.
33. Kulozik, A.E., Kar, B.C., Serjeant, G.R., Serjeant, B.E. & Weatherall, D.J. (1988) The molecular basis of alpha thalassemia in India. Its interaction with the sickle cell gene. Blood, 71, 467-472.
34. Landis, R.C., Philippidis, P., Domin, J., Boyle, J.J. & Haskard, D.O. (2013) Haptoglobin genotype-dependent anti-inflammatory signaling in CD163(+) macrophages. International Journal of Inflammation, 2013, 980327.
35. Langlois, M.R. & Delanghe, J.R. (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clinical Chemistry, 42, 1589-1600.
36. Lee, Y.S., Jung, K.H. & Roh, J.K. (2004) Diagnosis of moyamoya disease with transcranial Doppler sonography: correlation study with magnetic resonance angiography. Journal of Neuroimaging, 14, 319-323.
37. Makani, J., Kirkham, F.J., Komba, A., Ajala-Agbo, T., Otieno, G., Fegan, G., Williams, T.N., Marsh, K. & Newton, C.R. (2009) Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness. British Journal of Haematology, 145, 529-532.
38. Mason, P.J., Bautista, J.M. & Gilsanz, F. (2007) G6PD deficiency: the genotype-phenotype association. Blood Reviews, 21, 267-283.
39. McDermid, J.M. & Prentice, A.M. (2006) Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. Clinical Science (London), 110, 503-524.
40. Melamed-Frank, M., Lache, O., Enav, B.I., Szafranek, T., Levy, N.S., Ricklis, R.M. & Levy, A.P. (2001) Structure-function analysis of the antioxidant properties of haptoglobin. Blood, 98, 3693-3698.
41. Miller, S.T., Milton, J. & Steinberg, M.H. (2011) G6PD deficiency and stroke in the CSSCD. American Journal of Hematology, 86, 331.
42. Momin, E.N., Schwab, K.E., Chaichana, K.L., Miller-Lotan, R., Levy, A.P. & Tamargo, R.J. (2009) Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage. Neurosurgery, 65, 937-945; discussion 945.
43. Nakae, R., Yokota, H., Yoshida, D. & Teramoto, A. (2011) Transcranial Doppler ultrasonography for diagnosis of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mean blood flow velocity ratio of the ipsilateral and contralateral middle cerebral arteries. Neurosurgery, 69, 876-883; discussion 883.
44. Newton, C.R., Marsh, K., Peshu, N. & Kirkham, F.J. (1996) Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria. Pediatric Neurology, 15, 41-49.
45. Nichols, F.T., Jones, A.M. & Adams, R.J. (2001) Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. Journal of Neuroimaging, 11, 354-362.
46. Nouraie, M., Reading, N.S., Campbell, A., Minniti, C.P., Rana, S.R., Luchtman-Jones, L., Kato, G.J., Gladwin, M.T., Castro, O.L., Prchal, J.T. & Gordeuk, V.R. (2010) Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia. British Journal of Haematology, 150, 218-225.
47. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
48. Ohnishi, H., Iihara, K., Kaku, Y., Yamauchi, K., Fukuda, K., Nishimura, K., Nakai, M., Satow, T., Nakajima, N. & Ikegawa, M. (2013) Haptoglobin phenotype predicts cerebral vasospasm and clinical deterioration after aneurysmal subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases, 22, 520-526.
49. Pandey, D.K. & Gorelick, P.B. (2005) Epidemiology of stroke in African Americans and Hispanic Americans. Medical Clinics of North America, 89, 739-752, vii.
50. Pegelow, C.H., Wang, W., Granger, S., Hsu, L.L., Vichinsky, E., Moser, F.G., Bello, J., Zimmerman, R.A., Adams, R.J., Brambilla, D. & Trial, S. (2001) Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Archives of Neurology, 58, 2017-2021.
51. Prengler, M., Pavlakis, S.G., Boyd, S., Connelly, A., Calamante, F., Chong, W.K., Saunders, D., Cox, T., Bynevelt, M., Lane, R., Laverty, A. & Kirkham, F.J. (2005) Sickle cell disease: ischemia and seizures. Annals of Neurology, 58, 290-302.
52. Rees, D.C., Lambert, C., Cooper, E., Bartram, J., Goss, D., Deane, C. & Thein, S.L. (2009) Glucose 6 phosphate dehydrogenase deficiency is not associated with cerebrovascular disease in children with sickle cell anemia. Blood, 114, 742-743; author reply 743-744.
53. Sebastiani, P., Ramoni, M.F., Nolan, V., Baldwin, C.T. & Steinberg, M.H. (2005) Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nature Genetics, 37, 435-440.
54. Serjeant, B.E., Mason, K.P., Kenny, M.W., Stuart, J., Higgs, D.R., Weatherall, D.J., Hayes, R.J. & Serjeant, G.R. (1983) Effect of alpha thalassaemia on the rheology of homozygous sickle cell disease. British Journal of Haematology, 55, 479-486.
55. Stevens, M.C., Maude, G.H., Beckford, M., Grandison, Y., Mason, K., Taylor, B., Serjeant, B.E., Higgs, D.R., Teal, H. & Weatherall, D.J. (1986) Alpha thalassemia and the hematology of homozygous sickle cell disease in childhood. Blood, 67, 411-414.
56. Strouse, J.J., Cox, C.S., Melhem, E.R., Lu, H., Kraut, M.A., Razumovsky, A., Yohay, K., van Zijl, P.C. & Casella, J.F. (2006) Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA). Blood, 108, 379-381.
57. Thangarajh, M., Yang, G., Fuchs, D., Ponisio, M.R., McKinstry, R.C., Jaju, A., Noetzel, M.J., Casella, J.F., Barron-Casella, E., Hooper, W.C., Boulet, S.L., Bean, C.J., Pyle, M.E., Payne, A.B., Driggers, J., Trau, H.A., Vendt, B.A., Rodeghier, M. & DeBaun, M.R. (2012) Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. British Journal of Haematology, 159, 352-359.
58. Vardi, M., Blum, S. & Levy, A.P. (2012) Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. European Journal of Internal Medicine, 23, 628-632.
59. Wan, J., Ristenpart, W.D. & Stone, H.A. (2008) Dynamics of shear-induced ATP release from red blood cells. Proceedings of the National Academy of Sciences of the United States of America, 105, 16432-16437.
60. Williams, T.N., Mwangi, T.W., Wambua, S., Peto, T.E., Weatherall, D.J., Gupta, S., Recker, M., Penman, B.S., Uyoga, S., Macharia, A., Mwacharo, J.K., Snow, R.W. & Marsh, K. (2005) Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nature Genetics, 37, 1253-1257.